Janssen Pharmaceuticals has signed a licensing deal with Depomed for its Acuform gastric retentive drug delivery technology. As per the agreement, Janssen gained non-exclusive license and other rights to certain Acuform patents and in ...
Tags: Janssen Pharmaceuticals, Acuform Patents, drug delivery technology
Ophthalmologic products provider, InSite Vision has started the patient enrollment for the first Phase 3 clinical trial of BromSite (ISV-303), which is used to reduce pain and inflammation post cataract surgery. The study will enroll ...
Tags: Insite Vision, BromSite Phase 3 Study, Ophthalmologic products
Catalent Pharma Solutions has signed a supply agreement with Vivus to supply Qsymia capsules, a proprietary combination phentermine and extended-release topiramate. Catalent Modified Release Technologies president Ian Muir said Catalent ...
Tags: Qsymia capsules, extended-release topiramate, combination therapy
The subsidiary of Pristine Solutions, Eaton Scientific Systems, is planning to develop a transdermal patch delivery system for Tropine 3, a homatropine to treat non-hormonal hot flashes in pre-menopausal, peri-menopausal and post-menopausal ...
Tags: Transdermal Patch Delivery System, Eaton Scientific Systems, Tropine 3
Alitair Pharmaceuticals has gained a notice of allowance from the US Patent and Trademark Office for its ion exchange resin platform drug delivery technology, REA. Alitair has out-licensed two product candidates utilizing its REA platform ...
Tags: Alitair Pharmaceuticals, REA Drug Delivery Technology, US Patent
The US Patent and Trademark Office (USPTO) has granted three new patents to A.P. Pharma's new APF530 drug delivery candidate. The company said APF530 drug candidate is being developed for the prevention of both acute- and delayed-onset ...
Tags: US Patent, A.P.Pharma, APF530 drug delivery candidate, New Drug Delivery
BioTime has signed an exclusive sublicense agreement and a supply agreement with Jade Therapeutics for ophthalmological drug delivery applications of HyStem technology. According to the agreement, BioTime will provide Jade with ...
Tags: HyStem technology, Biotime, Jade Therapeutics, ophthalmological drug
BioDelivery Sciences International, a developer of drug delivery technologies, and Endo Health Solutions have started enrolling patients for its Phase 3 clinical program of BEMA Buprenorphine, designed as a treatment for moderate to severe ...
Tags: BioDelivery Sciences International, Endo Health Solutions
Catalent has started supplying its antipsychotic drug, Abilify, an orally disintegrating tablet (ODT) to Otsuka Pharmaceutical. Abilify ODT, which utilizes Catalent's Zydis fast dissolve drug delivery technology, is designed to improve ...
Tags: Catalent, Abilify Antipsychotic Drug, Otsuka Pharma, antipsychotic drug
Drug delivery CRO Particle Sciences has developed a new ocular formulation leveraging its proprietary polymer for Eyeon Therapeutics. The polymer used in the development of the new formulation demonstrated significant results compared to ...
Tags: Proprietary Polymer, Particle Sciences, New Ocular Formulation
Quotient Clinical and Capsugel have partnered to accelerate early development and clinical evaluation of lipid-based formulations. The collaboration will focus on addressing the drug delivery challenges of poorly soluble molecules with ...
Tags: Quotient, Poorly Soluble Molecules, Capsugel
Royer Biomedical(RBI)wins FDA approval to progress human testing of AppliGel-G(Gentamicin)in management of diabetic foot ulcers(DFU). The patented proprietary dissolvable non-immunogenic polymer drug delivery system platform has ...
Titan Pharmaceuticals has completed preclinical study of its long-term,non-fluctuating dopamine agonist,as a treatment for Parkinson's disease. The preclinical study included in-vitro characterization of implant formulations of two ...
Tags: Titan Pharmaceuticals, Parkinson's disease, ProNeura drug
Unilife has developed two new technologies for delivering injectable therapies to targeted regions of the eye. The new technologies include Unilife Depot-Ject platform which allows clinicians to implant a solid or oil based drug into the ...
Unilife Corporation's Unifill ready-to-fill(prefilled)syringe has received patent no.8,167,837 from the US Patent and Trademark Office(USPTO). The patent covers Unilife's proprietary technology,which integrates automatic and ...
Tags: Unilife, US Patent, Prefilled Syringe, Alan Shortall